ETST (Earth Science Tech) Receivables Turnover: 28.69 (As of Mar. 2026)


ETST Earth Science Tech Inc ETST
37 GF Score
Price $0.16
GF Value $0.24
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Earth Science Tech Receivables Turnover?

Earth Science Tech ETST +3.23% 37 Receivables Turnover is 28.69 as of Mar. 2026. GuruFocus rates ETST with a GF Score™ of 37/100 and a GF Value™ of $0.24 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 947 Drug Manufacturers companies, Earth Science Tech ranks better than 99.26% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Earth Science Tech's Revenue for the three months ended in Mar. 2026 was $9.50 Mil. Earth Science Tech's average Accounts Receivable for the three months ended in Mar. 2026 was $0.33 Mil. Hence, Earth Science Tech's Receivables Turnover for the three months ended in Mar. 2026 was 28.69.


Earth Science Tech  (OTCPK:ETST) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Earth Science Tech Receivables Turnover Related Terms


Earth Science Tech Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Earth Science Tech's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Earth Science Tech Receivables Turnover Chart

Earth Science Tech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.33 0.00 50.87 181.97 147.20

Earth Science Tech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.23 37.20 31.81 31.47 28.69

ETST vs IXHL, BTAI, TLPH: Receivables Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Earth Science Tech's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Earth Science Tech Receivables Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Earth Science Tech's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Earth Science Tech's Receivables Turnover falls into.


ETST
37GF Score
Earth Science Tech Inc ETST
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earth Science Tech Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Earth Science Tech's Receivables Turnover for the fiscal year that ended in Mar. 2026 is calculated as

Receivables Turnover (A: Mar. 2026 )
=Revenue / Average Accounts Receivable
=Revenue (A: Mar. 2026 ) / ((Accounts Receivable (A: Mar. 2025 ) + Accounts Receivable (A: Mar. 2026 )) / count )
=35.696 / ((0.129 + 0.356) / 2 )
=35.696 / 0.2425
=147.20

Earth Science Tech's Receivables Turnover for the quarter that ended in Mar. 2026 is calculated as

Receivables Turnover (Q: Mar. 2026 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Mar. 2026 ) / ((Accounts Receivable (Q: Dec. 2025 ) + Accounts Receivable (Q: Mar. 2026 )) / count )
=9.498 / ((0.306 + 0.356) / 2 )
=9.498 / 0.331
=28.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 28.69 mean?
Earth Science Tech (ETST) has a Receivables Turnover of 28.69 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Earth Science Tech and its competitors. According to the industry distribution chart, Earth Science Tech ranks #7 out of 947 companies in the Drug Manufacturers industry, placing it in the top 0.7%.
Is Earth Science Tech's Receivables Turnover too high?
Earth Science Tech's current Receivables Turnover is 28.69. The Drug Manufacturers industry median Receivables Turnover is 5.07. Earth Science Tech's value of 28.69 is 465.9% above this industry median. Based on the distribution chart, Earth Science Tech ranks #7 out of 947 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Earth Science Tech has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Earth Science Tech's Receivables Turnover compare to IXHL and BTAI?
According to the Drug Manufacturers industry distribution chart, Earth Science Tech ranks #7 out of 947 companies for Receivables Turnover. This places Earth Science Tech in the top 1% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.07. Earth Science Tech's value of 28.69 is 465.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 947 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Earth Science Tech's current Receivables Turnover of 28.69 is 465.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Earth Science Tech and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Earth Science Tech's current Receivables Turnover is 28.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Earth Science Tech stock overvalued right now?
Based on GuruFocus' analysis, Earth Science Tech (ETST) is currently considered Possible Value Trap. The stock's GF Value™ is $0.24, compared to a current price of $0.16 — trading 33.3% below its estimated fair value. The current Receivables Turnover is 28.69 and 465.9% above the Drug Manufacturers industry median of 5.07. Earth Science Tech's overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Earth Science Tech (ETST), the current Receivables Turnover is 28.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Earth Science Tech (ETST) Overvalued in 2026?

Based on GuruFocus' analysis, Earth Science Tech stock appears to be undervalued. The current stock price of $0.16 is trading 33.3% below its estimated GF Value™ of $0.24. GuruFocus considers Earth Science Tech to be Possible Value Trap.

Key valuation signals for ETST:

  • Receivables Turnover: 28.69
  • GF Value™: $0.24 vs. price of $0.16 (33.3% below fair value)
  • GF Score™: 37/100 with 3 warning signs
  • Industry Position: 465.9% above the Drug Manufacturers median (#7 of 947)

No single metric tells the full story. See the ETST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Earth Science Tech Business Description

Address 8950 SW 74th CT, Suite 1401, Miami, FL, USA, 33156
Earth Science Tech Inc is a diversified holding company. The company focuses on the health and wellness sector. The Company's principal operating plan is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The Company's healthcare operations are supported by investments in real estate and asset management activities and a consumer products business. The core of the Company's value proposition is the seamless integration of patient care, from consultation to fulfillment.
37GF Score

Get the complete analysis for ETST

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price
$0.24
GF Value